HIPRA España

Company Premium

HIPRA es una empresa farmacéutica biotecnológica enfocada en la prevención para la salud animal y humana, con una amplia gama de vacunas altamente innovadoras y un servicio de diagnóstico avanzado.

HIPRA trabaja con los últimos avances tecnológicos para crear soluciones que mejoren la salud global.

Los proyectos de I+D constituyen el núcleo del conocimiento, y es que, HIPRA cuenta con más de 50 años de experiencia dedicados a la investigación y desarrollo de diferentes vacunas. Con un modelo organizativo único, controla internamente todos los procesos de la cadena de valor, generando un know-how singular y convirtiéndose en un referente en la investigación, producción y comercialización de biológicos.

HIPRA tiene una sólida presencia internacional, las filiales comerciales y una red de distribución global, permiten que los productos lleguen a clientes de más de 100 países, cubriendo así los 5 continentes.

Send message

PRRSV in Europe: where did it come from?

The great genetic diversity of East European strains has practical implications, the sensitivity of some of the diagnostic PCR methods can be compromised and the efficacy of the current PRRSV vaccines against the East European genetic variants still needs to be elucidated.

Diagnosis of PRRS

Any tentative clinical diagnosis then should be confirmed by detection of PRRSV (infectious virus, viral antigens and/or viral genomic material) in affected pigs using laboratory methods in conjunction with typical lesions.

Highly Pathogenic PRRS (HP-PRRS) in Asia

A lot of work needs to be done for controlling HP-PRRS completely. The implementation of proper regional control and eradication programs against PRRS is necessary in China and the Asian countries. Meanwhile, the increasing diversity of the PRRSV should be taken into consideration for developing more effective and safe vaccines.

PRRS Immunology

Resolving the basis of viral and host variation will require identification and characterization of key B- and T-cell epitopes conserved among diverse PRRSV, and of the molecular and structural details of key effector antibodies, T-cell antigen receptors, and MHC molecules that mediate broad, cross-protective immunity.

Welcome to 333

Connect, share, and interact with the largest community of professionals in the swine industry.

Celebrating 153651Users on 333!

Sign upAlready a member?
Recommended accounts
Zhou  Lydia

Zhou Lydia

Other - China
DAVI  LIOU

DAVI LIOU

Other - China
Lallemand

Lallemand

Company - France
BASF

BASF

Company - Other